Clin2
NCT02338167Possibly a fitRecruiting

Study for pregnant women with breast cancer

Advanced/Metastatic Breast CancerBreast Cancer (Early Breast Cancer)

Treatments studied

Part of Cancer, Skin clinical trials.

This study is for adults with breast cancer who are pregnant and are either newly diagnosed (early) or have locally advanced or metastatic disease. It aims to better understand how breast cancer treatment should be managed during pregnancy.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
13,500 people
Ages
18 years to 99 years
Study type
Observational

Who can take part

  • You are at least 18 years old
  • You have breast cancer diagnosed recently (within the last 91 days) OR you have advanced disease that cannot be fully removed
  • Your breast cancer is invasive (not “in situ”/ductal carcinoma in situ)
  • There is no proof of distant metastases for the early group, or for the advanced/metastatic group it must be confirmed by standard scans
  • You can and agree to sign the informed consent form

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT05245136Recruiting
Blood test study for advanced cancer monitoring

This study uses a blood test (liquid biopsy) to look for tumor DNA in patients with advanced cancer. It aims to see if this test can help doctors monitor the cancer and make better treatment decisions.

Augsburg, Bavaria
NCT06048835Recruiting
Studying tumor cells in breast cancer patients

This trial looks at tumor cells in the blood of women with breast cancer to understand them better. It may help doctors learn more about how the disease spreads.

Pavia, Lombardy
NCT06833853Recruiting
Blood test study for women with advanced breast cancer

This study looks at a blood test that measures certain markers on cancer cells (CTCs) and genetic material in the blood (cfDNA/RNA) in women with metastatic breast cancer. It aims to better understand the cancer and guide treatment decisions.

Pittsburgh, Pennsylvania
NCT07860866Not yet recruiting
Blood test to monitor advanced breast cancer treatment

This study looks at whether a simple blood test can help doctors see how well treatment is working for advanced breast cancer that has stopped responding. It may help guide future care.

Pittsburgh, Pennsylvania
NCT04353557Recruiting
Blood test monitoring in early-stage breast cancer

This trial uses a special blood test to track cancer signals (called ctDNA) during and after treatment for early breast cancer. It aims to see whether monitoring these signals can help guide follow-up and treatment decisions.

Chongqing, Chongqing Municipality
NCT05370300Not yet recruiting
Blood and tissue study for newly diagnosed breast cancer patients

This study looks at blood and tissue samples from people newly diagnosed with breast cancer to better understand the disease and possibly find better ways to treat it. It is for people who have not yet started treatment, so it may be an opportunity to contribute to research early in your journey.

Durham, North Carolina

Hear when a new Advanced/Metastatic Breast Cancer trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.